Real-world study of treatment with Xeligekimab in patients with moderate to severe plaque psoriasis in Xinjiang region (ChiCTR) - Jul 23, 2026 - P=N/A | N=100 | Recruiting | Sponsor: Peoples Hospital of Xinjiang Uygur Autonomous Region; Peoples Hospital of Xinjiang Uygur Autonomous Region
New trial • Real-world evidence • Dermatology • Immunology • Psoriasis
|